78 related articles for article (PubMed ID: 10355748)
1. Identification and characterization of the putative retinoblastoma control element of the rat insulin-like growth factor binding protein-2 gene.
Kutoh E; Margot JB; Schwander J
Cancer Lett; 1999 Mar; 136(2):187-94. PubMed ID: 10355748
[TBL] [Abstract][Full Text] [Related]
2. Cell-density (cycle) dependent silencer of the rat insulin-like growth factor binding protein-2 (IGFBP-2) gene.
Kutoh E; Margot J; Schwander J
Growth Factors; 1999; 16(3):217-23. PubMed ID: 10372962
[TBL] [Abstract][Full Text] [Related]
3. Early phosphorylation of the retinoblastoma gene product regulates protein binding to the c-fos retinoblastoma control element during T cell activation.
Felzien LK; Branden MG; Benedict SH
Mol Immunol; 1997 May; 34(7):507-17. PubMed ID: 9364216
[TBL] [Abstract][Full Text] [Related]
4. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression.
Udvadia AJ; Rogers KT; Higgins PD; Murata Y; Martin KH; Humphrey PA; Horowitz JM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3265-9. PubMed ID: 8475068
[TBL] [Abstract][Full Text] [Related]
5. Identification of AP-2 as an interactive target of Rb and a regulator of the G1/S control element of the hamster histone H3.2 promoter.
Wu F; Lee AS
Nucleic Acids Res; 1998 Nov; 26(21):4837-45. PubMed ID: 9776742
[TBL] [Abstract][Full Text] [Related]
6. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
7. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Sellers WR; Novitch BG; Miyake S; Heith A; Otterson GA; Kaye FJ; Lassar AB; Kaelin WG
Genes Dev; 1998 Jan; 12(1):95-106. PubMed ID: 9420334
[TBL] [Abstract][Full Text] [Related]
8. Sp-1 binds promoter elements that are regulated by retinoblastoma and regulate CTP:phosphocholine cytidylyltransferase-alpha transcription.
Banchio C; Lingrell S; Vance DE
J Biol Chem; 2007 May; 282(20):14827-35. PubMed ID: 17384411
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression.
Udvadia AJ; Templeton DJ; Horowitz JM
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3953-7. PubMed ID: 7732011
[TBL] [Abstract][Full Text] [Related]
10. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
[TBL] [Abstract][Full Text] [Related]
11. Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box.
Brown AL; Rechler MM
Mol Endocrinol; 1990 Dec; 4(12):2039-51. PubMed ID: 1707131
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
13. Alterations in G1/S cell-cycle control contributing to carcinogenesis.
Kaelin WG
Ann N Y Acad Sci; 1997 Dec; 833():29-33. PubMed ID: 9616737
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of the rat cdc2 promoter in G1 by the silencer element.
Tsubota Y; Takeuchi A; Shimizu M; Nakajima T; Nojima H; Oda K
Cell Growth Differ; 1998 Mar; 9(3):257-65. PubMed ID: 9543392
[TBL] [Abstract][Full Text] [Related]
15. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
16. IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription.
Mireuta M; Darnel A; Pollak M
Growth Factors; 2010 Aug; 28(4):243-55. PubMed ID: 20370577
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
18. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
19. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
20. Cell-density-dependent modulation of the rat insulin-like-growth-factor-binding protein 2 and its gene.
Kutoh E; Schwander J; Margot JB
Eur J Biochem; 1995 Dec; 234(2):557-62. PubMed ID: 8536703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
